A prospective trial of midwest breast cancer patients: a p53 gene mutation is the most important predictor of adverse outcome.

A prospective trial of midwest breast cancer patients: a p53 gene mutation is the most important predictor of adverse outcome.

Item
http://www.wikidata.org/entity/Q54058828
Zeranol down-regulates p53 expression in primary cultured human breast cancer epithelial cells through epigenetic modificationPerspectives on the chemical etiology of breast cancer.Proteomic identification of heat shock protein 90 as a candidate target for p53 mutation reactivation by PRIMA-1 in breast cancer cellsp53 as a mutagen test in breast cancer.The prognostic molecular markers in hepatocellular carcinoma.TP53 and breast cancer.Glucose deprivation increases nuclear DNA repair protein Ku and resistance to radiation induced oxidative stress in human cancer cellsP53 immunohistochemical scoring: an independent prognostic marker for patients after hepatocellular carcinoma resection.A bioactive probe of the oxidative pentose phosphate cycle: novel strategy to reverse radioresistance in glucose deprived human colon cancer cells.Immunohistochemistry and scoring of Ki-67 proliferative index and p53 expression in gastric B cell lymphoma from Northern African population: a pilot study.State of the art of neoadjuvant chemotherapy in breast cancer: rationale, results and recent developments.The effect of immunohistochemically detected p53 accumulation in prognosis of breast cancer; A retrospective survey of outcome.A targeted mouse Brca1 mutation removing the last BRCT repeat results in apoptosis and embryonic lethality at the headfold stage.
P2860

A prospective trial of midwest breast cancer patients: a p53 gene mutation is the most important predictor of adverse outcome.

Item
http://www.wikidata.org/entity/Q54058828
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh
2000年學術文章
@zh-hant
name
A prospective trial of midwest ...... predictor of adverse outcome.
@en
A prospective trial of midwest ...... predictor of adverse outcome.
@nl
type
label
A prospective trial of midwest ...... predictor of adverse outcome.
@en
A prospective trial of midwest ...... predictor of adverse outcome.
@nl
prefLabel
A prospective trial of midwest ...... predictor of adverse outcome.
@en
A prospective trial of midwest ...... predictor of adverse outcome.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P356
P1433
P1476
A prospective trial of midwest ...... predictor of adverse outcome.
@en
P2093
P2860
P304
P31
P356
10.1002/(SICI)1097-0215(20000120)89:1<32::AID-IJC6>3.0.CO;2-G
P433
P478
P50
P577
P698